Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

MU Chemist Discovers Shortcut for Processing Drugs

09.03.2011
Prolific chemist adds another breakthrough to long list of accomplishments

A prolific University of Missouri chemist has discovered a quicker and easier method for pharmaceutical companies to make certain drugs.

Jerry Atwood, Curator's Professor and Chair of the Department of Chemistry
Jerry Atwood, Curator’s Professor and Chair of the Department of Chemistry in the MU College of Arts and Science, has recently published a paper – his 663rd in a refereed journal – that states that highly pressurized carbon dioxide at room temperature could replace the time consuming and expensive methods currently used to manufacture certain pharmaceutical drugs.

In the article, “A New Strategy of Transforming Pharmaceutical Crystal Forms,” published in a recent edition of the Journal of the American Chemical Society (JACS), Atwood and a team of researchers explain how manufacturers of popular drugs such as clarithromycin (an antibiotic drug) and lansoprazole (an acid reflux drug) could benefit from this process.

To develop basic drugs that are safe for people to consume, manufacturers must utilize chemistry to make specific crystals that constitute the eventual compound. Depending on the drug, current methods may include high-temperature heating, raw material altering, washing, filtering, and intensive drying. Atwood’s team found that pressurizing carbon dioxide can bring about the desired crystallization “with ease” and at normal room temperatures. Atwood said this discovery has the potential to streamline work flow and provide more safety for those who work with these chemicals.

“I believe this could have huge implications for the pharmaceutical industry,” Atwood said. “In addition to streamlining processes, pressurizing gas could circumvent some of the more difficult techniques used on an industrial scale, leading to better pharmaceuticals, more effective treatments and ultimately a lower price.”

Atwood points out that cost savings may be minimal to consumers, however, as drug companies set prices to recoup billion dollar investments in multiple-drug trials. Only one of every five clinically tested drugs makes it to market, Atwood said, and the companies must make a profit on the drug that becomes widely used.

The JACS paper was recognized by Chemical & Engineering News in its “News of the Week,” an accomplishment Atwood has achieved nine times. Despite all of his success, Atwood remains focused on his ultimate goal: to develop a chemotherapy drug with a magnetic component that could bring targeted delivery of medication, rather than the bloodstream saturation process used now.

“When I lecture a group of world-class scientists, I tell them the good news and the bad news,” Atwood said. “The bad news is that we must make a major breakthrough like curing a disease. If we can do that, then our field of chemistry will flourish, and we will pay society back for their investment. If we fail to make the breakthrough, society won’t support what we are doing forever. The good news is that just one of our research groups has to do it, so the pressure is on all or us, not just on you or me.”

Atwood is one of the top 50 chemists in the world in terms of citations and has published 663 papers in his career. The more citations a scientist has, the higher their rating known as the Hirsch index is. The H-index ranks international researchers according to the volume of published articles and the number of times those articles are cited, thus measuring a particular scientist’s influence. An H-index of 50 places a chemist in the top 500 worldwide. Atwood has an H-index of 83.

Steven Adams | EurekAlert!
Further information:
http://www.missouri.edu

More articles from Life Sciences:

nachricht 'Y' a protein unicorn might matter in glaucoma
23.10.2017 | Georgia Institute of Technology

nachricht Microfluidics probe 'cholesterol' of the oil industry
23.10.2017 | Rice University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>